Arunjyoti Bio (ABVL) | Stock Overview & Key Data
Arunjyoti Bio Performance Comparison
Stock Range
Today's Range
Low: ₹8.68
High: ₹9.58
on October 6, 2025
52 Week Range
Low: ₹5.05
High: ₹20.95
on August 18, 2025
on December 31, 2024
All-Time High: ₹30.07 on January 15, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.7B
EPS
-0.08
P/E Ratio (TTM)
55.46
Forward P/E
N/A
P/B Ratio
5.10
PEG Ratio
1.28
Div. Yield
N/A
ROE
-5.63%
Beta
-0.199
Debt to Equity
80.95
Financial Highlights
Profitability
Gross Margin
92.57%
Operating Margin
31.87%
Profit Margin
-4.34%
Returns and Earnings
Return on Assets (TTM)
-3.06%
Return on Equity (TTM)
-5.63%
EBITDA
INR52.6M
Net Income (TTM)
INR-11.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR1.42
Quarterly Revenue Growth (YoY)
-13.70%
Quarterly Earnings Growth (YoY)
39.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Arunjyoti Bio ABVL | 1.70B Small-cap | -18.41% | 27.69% | 43.10% | -24.48% | -52.57% | -26.25% | 121.60% | 1,041.25% |
| BLS International BLS | 140.79B Mid-cap | -1.15% | -10.92% | -9.30% | -18.34% | -31.75% | -6.88% | 16.56% | 732.11% |
| CMS Info Systems CMSINFO | 64.02B Mid-cap | 0.20% | -8.22% | -24.77% | -20.38% | -24.45% | -35.80% | 24.06% | 59.84% |
| PDS PDSL | 44.02B Small-cap | -6.33% | -1.03% | -22.04% | -25.83% | -45.90% | -37.89% | 9.07% | 398.75% |
| Jaykay Enterprises JAYKAY | 30.08B Small-cap | 7.57% | 53.42% | 56.65% | 74.13% | 84.79% | 141.58% | 255.78% | 4,710.42% |
| Hinduja Global HGS | 23.49B Small-cap | -0.55% | -3.70% | -10.20% | 4.22% | -28.79% | -36.35% | -61.40% | 39.85% |
Ownership & Short Interest
Insider Ownership
75.42%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
169K
Average 90-Day Volume
387K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ABVL's 52-week high and low?
- In the last 52 weeks, Arunjyoti Bio reached a high of ₹20.95 (on December 31, 2024) and a low of ₹5.05 (on August 18, 2025).
- What is the market cap and P/E ratio for ABVL?
- Curious about Arunjyoti Bio's size and valuation? Its market capitalization stands at 1.70B. When it comes to valuation, the P/E ratio (trailing twelve months) is 55.46, and the forward P/E (looking ahead) is N/A.
- Does ABVL pay dividends? If so, what's the yield?
- As for dividends, Arunjyoti Bio isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Arunjyoti Bio's main competitors or similar companies to consider before investing?
When looking at Arunjyoti Bio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return BLS International
BLS140.79B Industrials Specialty Business Services -6.88% 16.56% CMS Info Systems
CMSINFO64.02B Industrials Specialty Business Services -35.80% 24.06% PDS
PDSL44.02B Industrials Specialty Business Services -37.89% 9.07% Jaykay Enterprises
JAYKAY30.08B Industrials Specialty Business Services 141.58% 255.78% Hinduja Global
HGS23.49B Industrials Specialty Business Services -36.35% -61.40% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Arunjyoti Bio Ventures Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Arunjyoti Bio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.63%, the Debt to Equity ratio from the most recent quarter is 80.95, and its Gross Profit Margin stands at 92.57%.
- What is the recent revenue and earnings growth for ABVL?
- Looking at Arunjyoti Bio's growth, its revenue over the trailing twelve months (TTM) was INR265M. Compared to the same quarter last year (YoY), quarterly revenue grew by -13.70%, and quarterly earnings saw a YoY growth of 39.70%.
- How much of ABVL stock is held by insiders and institutions?
- Wondering who owns Arunjyoti Bio stock? Company insiders (like executives and directors) hold about 75.42% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.